If you are interested.....

....in reading more about the tedious MRSA screening debate, I wrote one half of a pro-con piece for the March issue of the Journal of Clinical Microbiology (can you guess which half I wrote?).

I don’t like the “pro-con” format for this issue, because it tends to oversimplify the role of multidrug resistant organism (MDRO) screening in MDRO prevention. If the question is whether screening for asymptomatic MDRO carriage can be a valuable tool in certain situations, the answer is “yes”. If the question is whether every hospital should be forced, by directive or legislative mandate, to screen everyone for a specific MDRO….then, well, my answer is “no”. SHEA and APIC feel the same way, apparently.


Most Read Posts (Last 30 Days)